Early-onset vasculitis: a toddler with ADA2 deficiency.

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Deficiency of adenosine deaminase 2 (DADA2) is an autoinflammatory disease.
• It results from loss-of-function mutations in the ADA2 gene, decreasing plasma ADA2 levels.
• ADA2 is crucial for immune system maturation, differentiation, and homeostasis.

Purpose of the Study:

• To report a fatal case of DADA2 in an infant.
• To emphasize the impact of delayed diagnosis and treatment.
• To highlight bone marrow transplantation as a definitive therapy.

Main Methods:

• Case report of an infant with DADA2.
• Review of disease pathophysiology and treatment options.
• Analysis of diagnostic and therapeutic timelines.

Main Results:

• The infant experienced a fatal outcome due to delayed diagnosis and treatment.
• The case underscores the critical role of ADA2 in immune function.
• Bone marrow transplantation is a potentially curative treatment.

Conclusions:

• Early diagnosis and prompt initiation of bone marrow transplantation are vital for managing DADA2.
• This case highlights the severe consequences of delayed intervention in DADA2.
• Further research into ADA2 function and DADA2 management is warranted.